Manufacturers reduce MRP on 3 anticancer drugs after BCD, GST cuts: Centre

IANS | December 6, 2024 8:35 PM

New Delhi, Dec 6 (IANS) Manufacturers have started to reduce the maximum retail price (MRP) on three anticancer drugs -- Trastuzumab Deruxtecan, Osimertinib, and Durvalumab drugs -- as directed by the government to pass on the benefits to the consumers, the Parliament was informed on Friday.